January 27, 2023
MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
Obat Herbal Tiens Blog Obat Herbal Tiens Solusi Sehat Untuk Semua
Bahan alami yang digunakan dalam pembuatan obat herbal sangat efektif untuk menyembuhkan berbagai penyakit dan menjaga kesehatan tanpa efek samping. Dibandingkan dengan obat yang beredar saat ini, obat herbal lebih aman karena tidak menggunakan bahan kimia. Sebagian besar obat yang beredar dipasaran adalah obat yang menggunakan bahan kimia yang menimbulkan efek samping dan masalah kesehatan [...]
Read full article »
January 26, 2023
FinanzNachrichten
Lilly Supports Direct Relief's Efforts To Expand Access to Medicines by Improving Cold Chain Capacity
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief:Eli Lilly and ... See more »
January 26, 2023
Zacks
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in... See more »
January 26, 2023MarketScreener
Cambium Networks Corporation Announces Fourth Quarter and Full Year 2022 Reporting Date
(marketscreener.com) ROLLING MEADOWS, Ill., Jan. 26, 2023 /PRNewswire/ -- Cambium Networks Corporatio... See more »
January 26, 2023Legal Futures
Law firm sues Trustpilot for defamation over 20 negative reviews
A law firm is suing Trustpilot for defamation over 20 negative reviews that accuse it of pursuing deb... See more »
January 27, 2023Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
January 25, 2023Nasdaq
Why Abbott Laboratories Stock Got Whacked on Wednesday
What happened Wednesday morning, Abbott Laboratories (NYSE: ABT) beat on both the top and bottom line... See more »
January 25, 2023Pharmabiz
US FDA accepts Boehringer Ingelheim & Eli Lilly's sNDA for Jardiance for adults with chronic kidney disease
Boehringer Ingelheim and Eli Lilly and Company announced that the US Food and Drug Administration (FD... See more »
January 25, 2023Moneycontrol
Cipla Q3 Result | Profit rises 10% YoY to Rs 801 crore, revenue up 6%
NULL... See more »
January 27, 2023
MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
January 26, 2023
FinanzNachrichten
Lilly Supports Direct Relief's Efforts To Expand Access to Medicines by Improving Cold Chain Capacity
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief:Eli Lilly and ... See more »
January 26, 2023
Zacks
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in... See more »
January 26, 2023MarketScreener
Cambium Networks Corporation Announces Fourth Quarter and Full Year 2022 Reporting Date
(marketscreener.com) ROLLING MEADOWS, Ill., Jan. 26, 2023 /PRNewswire/ -- Cambium Networks Corporatio... See more »
January 26, 2023Legal Futures
Law firm sues Trustpilot for defamation over 20 negative reviews
A law firm is suing Trustpilot for defamation over 20 negative reviews that accuse it of pursuing deb... See more »
January 27, 2023Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
January 25, 2023Nasdaq
Why Abbott Laboratories Stock Got Whacked on Wednesday
What happened Wednesday morning, Abbott Laboratories (NYSE: ABT) beat on both the top and bottom line... See more »
January 25, 2023Pharmabiz
US FDA accepts Boehringer Ingelheim & Eli Lilly's sNDA for Jardiance for adults with chronic kidney disease
Boehringer Ingelheim and Eli Lilly and Company announced that the US Food and Drug Administration (FD... See more »
January 25, 2023Moneycontrol
Cipla Q3 Result | Profit rises 10% YoY to Rs 801 crore, revenue up 6%
NULL... See more »
